Status:
UNKNOWN
Combined Antihypertensive Therapy and Sexual Dysfunction
Lead Sponsor:
LanZhou University
Conditions:
Hypertension
Sexual Dysfunction
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
This randomized,active controlled study aimed to compare the effects on sexual function of treatment with combined antihypertensive drugs. The researchers hypothesize that: 1. Both felodipine-irbesa...
Detailed Description
The effects of hypertension and its pharmacotherapy on sexual function are well known in men,although this topic remains unexplored in women.There is evidence suggests that some classes of antihyperte...
Eligibility Criteria
Inclusion
- Patients with essential hypertension.
- Initial hypertension, or without taking any antihypertensive for at least one month.
- Sexual active.
Exclusion
- Patients with secondary hypertension.
- Patients with malignant hypertension, coronary heart disease, diabetes, a history of syncope, bradycardia (heart rate \<45 beats / min), atrioventricular block(Ⅱ or Ⅲ degree), sick sinus syndrome, congestive heart failure, a history of cerebral vascular accidents, serious hepatic and kidney dysfunction, a history of serious mental illness, pregnant, taking oral exogenous estrogens (including contraceptives), hysterectomy, breastfeeding, a history of alcohol or drug abuse, having serious conflict with sexual partner, severity sexual dysfunction.
- Patients refuse to answer questions, refuse to fill in the questionaires,or do not willing to take blood examination.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2010
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT01238705
Start Date
April 1 2008
End Date
November 1 2010
Last Update
November 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Hospital of Lanzhou University
Lanzhou, Gansu, China, 730000